XML 17 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Statements of Cash Flows - USD ($)
 6 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities    
Net loss $ (10,541,576) $ (5,608,568)
Stock-based compensation expense 1,425,133 250,887
Depreciation, amortization and accretion 1,722,965 242,427
Issuance of restricted stock 156,814 0
Amortization of debt issuance costs 0 147,805
Derivative (income) expense (196,148) 78,038
Amortization of prepaid research and development - related party (Note 10) 60,992 60,991
Common stock issued to executives 509,996 0
Issuance of warrants to initial investors 596,434 0
Unrealized (gain) on investment (230,936) 0
Adjustments to reconcile net loss to net cash used in operating activities:    
(Increase) in accounts receivable (419,966) (131,408)
Decrease (increase) in inventory 85,741 (613,673)
(Increase) in prepaid expenses and other (221,015) (370,656)
(Decrease) in accounts payable and accrued liabilities (434,231) (126,781)
Increase in related party payable 0 38,451
(Decrease) increase in accrued compensation (681,432) 296,081
Increase in interest payable 0 161,988
(Decrease) increase in deferred rent (1,350) 10,245
(Decrease) in deferred revenue 0 (42,857)
Net cash used in operating activities (8,168,579) (5,607,030)
Cash flows used in investing activities    
Deposits 0 1,998
Purchases of fixed assets (44,876) (125,161)
Installment payment for Natesto asset (2,000,000) 0
Installment payments for Primsol asset (750,000) (540,000)
Net cash used in investing activities (2,794,876) (663,163)
Cash flows from financing activities    
Ampio stock subscription payment 0 5,000,000
Proceeds from convertible promissory notes, net 0 5,175,000
Debt issuance costs (Note 7) 0 (298,322)
Issuance of common stock to Lincoln Park Capital 631,481 0
Costs related to sale of common stock (24,247) 0
Registered offering of common stock and warrants 8,602,500 0
Registered offering costs (997,865) 0
Over-allotment warrants purchased by placement agents 2,852  
Net cash provided by financing activities 8,214,721 9,876,678
Net change in cash, cash equivalents and restricted cash (2,748,734) 3,606,485
Cash, cash equivalents and restricted cash at beginning of period 8,054,190 7,353,061
Cash, cash equivalents and restricted cash at end of period 5,230,394 10,959,546
Non-cash transactions:    
Warrant derivative liability related to the issuance of the convertible promissory notes 102,931
Primsol business purchase included in primsol payable, $1,250,000 less future accretion of $173,000 1,077,000
Fixed assets included in accounts payable 61,241 7,708
Warrants issued in connection with the equity financing to the placement agents $ 292,630 $ 0